Multi-center results confirm durability of USGI Medical's Expandable Tissue Anchors

Enables numerous incisionless gastrointestinal procedures; results presented at IFSO 2010

USGI Medical, Inc., the Incisionless Surgery company, today announced that updated multi-center results confirm durability of the company's Expandable Tissue Anchors- up to a year or more in a variety of incisionless gastrointestinal (GI) procedures, including use of a ROSE procedure (Repair of Surgery, Endolumenal) to repair dilated tissue after gastric bypass.

These findings, which demonstrate long-term, secure tissue approximation with this scarless "through the mouth" approach in the largest cohort of patients ever reported, underscore the utility of the company's Incisionless Operating Platform- (IOP) and these anchors for durably suturing GI tissue.

Surgeon Peter Denk, MD presented the results to an international audience as part of the scientific program at IFSO 2010, the annual meeting of the International Federation for the Surgery of Obesity and Metabolic Disorders, which took place in Long Beach, Calif. from September 3 to 7.

"Stomach tissue is extremely resistant to change and showing long-term durability of procedures utilizing endoscopic sutures or staples has proven difficult," said Dr. Denk, who operates out of the Lehigh Regional Medical Center in Fort Myers, Florida. "A special suture design that spreads forces and can adapt with the patient's anatomy is necessary when anchoring tissue from inside the stomach or GI tract. These results demonstrate durability of these expandable tissue anchors for over a year, offering surgeons a feasible approach when performing numerous incisionless GI procedures through the mouth."

Surgeons across the U.S. and in the European Union are using the IOP to perform ROSE in a number of applications, including repair of dilated stomach pouches and stomas after gastric bypass surgery, repair of gastro-gastric fistulas (a common complication that arises after Roux-en-Y gastric bypass), and slipped Nissen fundoplications for GERD. They also have used the IOP to close stomach incisions after removing the gall bladder through the stomach/mouth in NOTES (Natural Orifice Translumenal Endoscopic Surgery) cholecystectomy operations.

To perform these procedures, surgeons pass the flexible USGI IOP down a patient's throat and use these tools to grasp tissue and deploy the Expandable Tissue Anchors to create desired tissue folds that re-shape the stomach or close incisions in the stomach. An endoscope provides visualization during the procedures.

Of the patients who had ROSE for dilated pouch and stoma repair, data presented showed that 92% of those who underwent 12-month endoscopies>

Similarly, tissue anchors were visible during 24-month follow-up endoscopies in all five of the patients who had NOTES cholecystectomies. No serious adverse events, ulcerations, or strictures were reported.

The devices that make up the IOP have 510(k) clearance in the U.S. for tissue approximation in minimally invasive GI procedures and also received the European CE Mark in March 2010. USGI markets the IOP to surgeons in the U.S. and works closely with its distribution partners to build Incisionless Surgery Centers worldwide.